We are live on !
Find out more
Creative Planning Portfolio holdings
AUM
$171B
Turnover
10.62%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter Est. Return
+14.14%
1 Year Est. Return
+24.68%
3 Year Est. Return
+62.17%
5 Year Est. Return
+55.89%
10 Year Est. Return
+171.9%
AUM
$171B
AUM Growth
+$23.7B
(+16%)
Cap. Flow
+$6.93B
Cap. Flow % of AUM
Cap. Flow %
4.05%
Top 10 Holdings %
Top 10 Hldgs %
41.66%
Holding
4,427
New
337
Increased
2,605
Reduced
1,239
Closed
133
Avg Time Held
Equity + Options
4.2
years
Top 10 Avg Time Held
Equity + Options
1.7
years
Top 20 Avg Time Held
Equity + Options
4.3
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
1.7
years
Top 20 Avg Time Held Equity only
4.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$682M |
| 2 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$526M |
| 3 |
Vanguard Short-Term Bond ETF
BSV
|
+$504M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$431M |
| 5 |
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$239M |
| 2 |
Vanguard Morningstar Large-Cap ETF
VV
|
+$74.4M |
| 3 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$41.1M |
| 4 |
Honeywell
HON
|
+$39.3M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 73.8% |
| 2 | Technology | 9.57% |
| 3 | Financials | 3.79% |
| 4 | Industrials | 2.49% |
| 5 | Healthcare | 2.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
4151
Castellum
CTM
$53.5M
| $36K | ﹤0.01% |
50,000
+29,680
| +146% | +$21.1K |
2025 Q1
5 quarters
|
|
4152
DELISTED
Cosan
CSAN
| $35.9K | ﹤0.01% |
+12,474
| New | +$44.2K |
2026 Q2
0 quarters
|
|
4153
Hain Celestial
HAIN
$14.3M
| $35.8K | ﹤0.01% |
63,887
+39,197
| +159% | +$29.1K |
2025 Q4
2 quarters
|
|
4154
CALL
United States Gasoline Fund
UGA
$167M
| $35.6K | ﹤0.01% |
+16,000
| New | +$1.73M |
2026 Q2
0 quarters
|
|
4155
Codexis
CDXS
$143M
| $35K | ﹤0.01% |
+15,488
| New | +$38.6K |
2026 Q2
0 quarters
|
|
4156
Gossamer Bio
GOSS
$57.9M
| $34.9K | ﹤0.01% |
2,649
+1,079
| +69% | +$24.1K |
2025 Q3
3 quarters
|
|
4157
Embecta
EMBC
$389M
| $34.5K | ﹤0.01% |
10,583
-39,564
| -79% | -$216K |
2024 Q2
8 quarters
|
|
4158
Nano Dimension
NNDM
$581M
| $33.7K | ﹤0.01% |
23,246
+1,159
| +5% | +$1.89K |
2020 Q2
24 quarters
|
|
4159
eHealth
EHTH
$17.6M
| $33.5K | ﹤0.01% |
22,464
+8,082
| +56% | +$13.5K |
2026 Q1
1 quarter
|
|
4160
Ocugen
OCGN
$268M
| $33.4K | ﹤0.01% |
21,837
-4,250
| -16% | -$6.46K |
2025 Q2
4 quarters
|
|
4161
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$810B
| $33.3K | ﹤0.01% |
+6,100
| New | +$4.42M |
2026 Q2
0 quarters
|
|
4162
NervGen Pharma
NGEN
$153M
| $32.1K | ﹤0.01% |
15,575
+2,638
| +20% | +$8.19K |
2026 Q1
1 quarter
|
|
4163
enCore Energy
EU
$150M
| $31.8K | ﹤0.01% |
24,262
-23,992
| -50% | -$40.3K |
2025 Q1
5 quarters
|
|
4164
POET Technologies
POET
$922M
| $30.8K | ﹤0.01% |
+3,000
| New | +$32.7K |
2026 Q2
0 quarters
|
|
4165
Orion Office REIT
ONL
$123M
| $30.8K | ﹤0.01% |
+10,658
| New | +$29.2K |
2026 Q2
0 quarters
|
|
4166
Alector
ALEC
$204M
| $30.2K | ﹤0.01% |
+15,015
| New | +$32.2K |
2026 Q2
0 quarters
|
|
4167
Standard Lithium
SLI
$370M
| $29.8K | ﹤0.01% |
10,841
-2,360
| -18% | -$8.59K |
2026 Q1
1 quarter
|
|
4168
Claros Mortgage Trust
CMTG
$171M
| $29.8K | ﹤0.01% |
12,684
+1,211
| +11% | +$2.97K |
2025 Q3
3 quarters
|
|
4169
Elme Communities
ELME
$157M
| $27.7K | ﹤0.01% |
18,705
-18,421
| -50% | -$37.3K |
2025 Q1
5 quarters
|
|
|
4170
PUT
iShares Core S&P 500 ETF
IVV
$876B
| $27.2K | ﹤0.01% |
+2,500
| New | +$1.82M |
2026 Q2
0 quarters
|
|
4171
Aptera Motors
SEV
$58.9M
| $26.7K | ﹤0.01% |
10,917
| – | – |
2026 Q1
1 quarter
|
|
4172
Sol Strategies Inc
STKE
$50M
| $26.3K | ﹤0.01% |
22,510
| – | – |
2026 Q1
1 quarter
|
|
4173
CALL
Generac Holdings
GNRC
$11.1B
| $25.8K | ﹤0.01% |
+200
| New | +$50.1K |
2026 Q2
0 quarters
|
|
4174
ADC Therapeutics
ADCT
$204M
| $25.7K | ﹤0.01% |
24,032
-55,002
| -70% | -$160K |
2025 Q2
4 quarters
|
|
4175
Cognition Therapeutics
CGTX
$66.6M
| $25.5K | ﹤0.01% |
22,200
-8,004
| -26% | -$9.47K |
2025 Q1
5 quarters
|
|
Similar funds
Creative Planning's Q2 2026 Portfolio in Review
As of Q2 2026, Creative Planning held 4,427 positions worth $171B, up 16% from $147B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Creative Planning deployed $6.93B of net new capital in Q2 2026, opening 337 new positions and adding to 2,605 existing holdings. Its largest new stake was Honeywell Aerospace: 169,880 shares worth $37.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 74% of assets, down from 76% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $239M trimmed.
- Creative Planning's largest Q2 2026 buy was Honeywell Aerospace: 169,880 shares worth $37.6M.
- Creative Planning added most to Vanguard Total Bond Market in Q2 2026, an estimated $682M increase.
- Creative Planning's biggest Q2 2026 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $239M.
- Creative Planning fully exited Hologic in Q2 2026, selling an estimated $8.29M.
- Creative Planning's ten largest holdings make up 42% of its $171B portfolio in Q2 2026.
- Creative Planning opened 337 new positions and closed 133 in Q2 2026.
- Creative Planning's portfolio value rose 16% quarter-over-quarter to $171B.
Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.